Author:
Gomez Scarlett Lin,Tsai Chiaojung Jillian
Publisher
Springer Science and Business Media LLC
Reference10 articles.
1. Owens-Walton, J., Williams, C., Rompré-Brodeur, A., Pinto, P. A. & Ball, M. W. Minority enrollment in phase ii and iii clinical trials in urologic oncology. J. Clin. Oncol. https://doi.org/10.1200/JCO.21.01885 (2022).
2. National Cancer Institute. Surveillance, Epidemiology, End Results Program. Number of Persons by Race and Hispanic Ethnicity for SEER Participants (2020 Census Data), https://seer.cancer.gov/registries/data.html (accessed 17 March 2022).
3. Borno, H. T. et al. How current reporting practices may mask differences: a call for examining cancer-specific demographic enrollment patterns in cancer treatment clinical trials. Contemp. Clin. Trials Commun. 16, 100476 (2019).
4. Anderson, A. & Griffith, D. M. Measuring the Trustworthiness of Health Care Organizations and Systems. Milbank Q. https://doi.org/10.1111/1468-0009.12564 (2022).
5. Jones, L. & Wells, K. Strategies for academic and clinician engagement in community-participatory partnered research. J. Am. Med. Assoc. 297, 407–410 (2007).
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献